Correlation between ultrasound findings of thyroid imaging reporting and data system II and III thyroid nodules and fine-needle aspiration results
- 1Clinical Radiology and Medical Imaging department, Clinical Radiology and Medical Imaging, Kurdistan Higher Council of Medical Specialties, Sulaymaniyah Teaching Hospital/Radiology Center.
Abstract
Background and objectives Thyroid nodules are common clinical findings, and their detection rate is increasing owing to the widespread use of high-resolution ultrasonography. Accurate risk stratification is essential to avoid unnecessary, invasive procedures. The American College of Radiology Thyroid Imaging Reporting and Data System (ACR-TIRADS) was developed to standardize ultrasound evaluation and guide the need for fine-needle aspiration (FNA). This study aimed to evaluate the correlation between ultrasound-based ACR-TIRADS II and III classifications and fine-needle aspiration cytology (FNAC) results using the Bethesda System. Patients and methods A prospective observational cross-sectional study was conducted at Sulaymaniyah Teaching Hospital between December 2024 and December 2025. Ninety adults with thyroid nodules classified as ACR-TIRADS II (n = 27) or III (n = 63) who underwent ultrasound-guided FNA as part of routine clinical care were included. Cytology was categorized using the Bethesda System. The primary analysis assessed the distribution of Bethesda categories by TIRADS group; Bethesda V-VI was additionally evaluated as a high-risk cytology endpoint rather than as histopathologically confirmed malignancy. Results Bethesda II cytology was more frequent in ACR-TIRADS II than ACR-TIRADS III nodules (88.9% vs 54.0%; Fisher exact P = 0.002). Bethesda V-VI cytology occurred in 3.7% of ACR-TIRADS II and 17.5% of ACR-TIRADS III nodules (Fisher exact P = 0.099). The overall 2×6 ACR-TIRADS-Bethesda System distribution did not reach conventional statistical significance (Pearson χ2 = 10.67, df = 5, P = 0.058). Using ACR-TIRADS III as the positive category for predicting Bethesda V-VI cytology yielded a sensitivity of 91.7% (95% CI 61.5–99.8), specificity of 33.3% (23.1–44.9), PPV of 17.5% (9.1–29.1), NPV of 96.3% (81.0–99.9), and overall accuracy of 41.1% (30.8–52.0). Conclusions In this selected cohort of biopsied low-risk nodules, TIRADS II was predominantly associated with benign cytology, while TIRADS III showed a higher proportion of Bethesda V-VI outcomes. These findings support the value of ACR-TIRADS as a risk-stratification framework, but they should not be interpreted as evidence to omit or mandate FNA outside established size and clinical criteria because histopathological confirmation and longitudinal follow-up were not available.
Related
- Diagnostic Accuracy of Fine Needle Aspiration Cytology in Thyroid Diseases: Comparison with Histopathological Findings in Hawassa, Ethiopia
- Concordance Study on Molecular Detection of Thyroid Nodules by Ultrasound Guided Fine Needle Aspiration
- Imaging Correlation of Color Doppler Ultrasound, CT Angiography, and MR Angiography Findings in Extracranial Carotid and Vertebral Artery Disease Among Ischemic Stroke Patients: A Prospective Observational Study.
- Ultrasound-guided percutaneous fine-needle aspiration in parapharyngeal space lesions: a critical appraisal with illustrative cases
- Cytology smears from endobronchial ultrasound-guided transbronchial needle aspiration as a source of nucleic acids with adequate yield for next-generation sequencing
BibTeX
@article{roshen2026correlation,
title = {{Correlation between ultrasound findings of thyroid imaging reporting and data system II and III thyroid nodules and fine-needle aspiration results}},
author = {Tara Roshen and Naser Abdullah Mohammed},
journal = {The Egyptian Journal of Radiology and Nuclear Medicine},
year = {2026},
month = oct,
doi = {10.1186/s43055-026-01887-w},
url = {https://doi.org/10.1186/s43055-026-01887-w},
note = {CC BY},
}
RIS
TY - JOUR
TI - Correlation between ultrasound findings of thyroid imaging reporting and data system II and III thyroid nodules and fine-needle aspiration results
AU - Tara Roshen
AU - Naser Abdullah Mohammed
PY - 2026
DA - 2026/10/25
JO - The Egyptian Journal of Radiology and Nuclear Medicine
DO - 10.1186/s43055-026-01887-w
UR - https://doi.org/10.1186/s43055-026-01887-w
AB - Background and objectives Thyroid nodules are common clinical findings, and their detection rate is increasing owing to the widespread use of high-resolution ultrasonography. Accurate risk stratification is essential to avoid unnecessary, invasive procedures. The American College of Radiology Thyroid Imaging Reporting and Data System (ACR-TIRADS) was developed to standardize ultrasound evaluation and guide the need for fine-needle aspiration (FNA). This study aimed to evaluate the correlation between ultrasound-based ACR-TIRADS II and III classifications and fine-needle aspiration cytology (FNAC) results using the Bethesda System. Patients and methods A prospective observational cross-sectional study was conducted at Sulaymaniyah Teaching Hospital between December 2024 and December 2025. Ninety adults with thyroid nodules classified as ACR-TIRADS II (n = 27) or III (n = 63) who underwent ultrasound-guided FNA as part of routine clinical care were included. Cytology was categorized using the Bethesda System. The primary analysis assessed the distribution of Bethesda categories by TIRADS group; Bethesda V-VI was additionally evaluated as a high-risk cytology endpoint rather than as histopathologically confirmed malignancy. Results Bethesda II cytology was more frequent in ACR-TIRADS II than ACR-TIRADS III nodules (88.9% vs 54.0%; Fisher exact P = 0.002). Bethesda V-VI cytology occurred in 3.7% of ACR-TIRADS II and 17.5% of ACR-TIRADS III nodules (Fisher exact P = 0.099). The overall 2×6 ACR-TIRADS-Bethesda System distribution did not reach conventional statistical significance (Pearson χ2 = 10.67, df = 5, P = 0.058). Using ACR-TIRADS III as the positive category for predicting Bethesda V-VI cytology yielded a sensitivity of 91.7% (95% CI 61.5–99.8), specificity of 33.3% (23.1–44.9), PPV of 17.5% (9.1–29.1), NPV of 96.3% (81.0–99.9), and overall accuracy of 41.1% (30.8–52.0). Conclusions In this selected cohort of biopsied low-risk nodules, TIRADS II was predominantly associated with benign cytology, while TIRADS III showed a higher proportion of Bethesda V-VI outcomes. These findings support the value of ACR-TIRADS as a risk-stratification framework, but they should not be interpreted as evidence to omit or mandate FNA outside established size and clinical criteria because histopathological confirmation and longitudinal follow-up were not available.
SN - 2090-4762
SN - 0378-603X
ER -